Utah Medical Products (NASDAQ:UTMD) Stock Crosses Above Fifty Day Moving Average – What’s Next?

Utah Medical Products, Inc. (NASDAQ:UTMD) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $56.49 and traded as high as $58.76. Utah Medical Products shares last traded at $57.60, with a volume of 19,913 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Utah Medical Products in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Utah Medical Products currently has an average rating of “Sell”.

Utah Medical Products Price Performance

The stock has a fifty day simple moving average of $56.49 and a 200-day simple moving average of $58.38. The company has a market capitalization of $184.55 million, a price-to-earnings ratio of 16.27 and a beta of 0.33.

Utah Medical Products (NASDAQ:UTMD) last issued its quarterly earnings data on Thursday, October 23rd. The medical instruments supplier reported $0.82 EPS for the quarter. Utah Medical Products had a net margin of 30.08% and a return on equity of 9.89%. The business had revenue of $9.81 million for the quarter.

Utah Medical Products Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, January 5th. Shareholders of record on Tuesday, December 16th were issued a $0.31 dividend. The ex-dividend date of this dividend was Tuesday, December 16th. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.31. This represents a $1.24 dividend on an annualized basis and a yield of 2.2%. Utah Medical Products’s dividend payout ratio is presently 35.03%.

Institutional Investors Weigh In On Utah Medical Products

A number of institutional investors have recently modified their holdings of the business. Brandes Investment Partners LP lifted its position in shares of Utah Medical Products by 12.0% during the 2nd quarter. Brandes Investment Partners LP now owns 271,322 shares of the medical instruments supplier’s stock valued at $15,444,000 after buying an additional 29,073 shares in the last quarter. LSV Asset Management increased its holdings in Utah Medical Products by 8.8% in the 2nd quarter. LSV Asset Management now owns 12,974 shares of the medical instruments supplier’s stock worth $738,000 after acquiring an additional 1,053 shares in the last quarter. Minerva Advisors LLC raised its position in Utah Medical Products by 7.1% during the second quarter. Minerva Advisors LLC now owns 93,058 shares of the medical instruments supplier’s stock worth $5,267,000 after acquiring an additional 6,156 shares during the period. R Squared Ltd purchased a new position in Utah Medical Products during the second quarter valued at $209,000. Finally, Cardinal Capital Management lifted its holdings in Utah Medical Products by 4.2% during the second quarter. Cardinal Capital Management now owns 22,780 shares of the medical instruments supplier’s stock valued at $1,304,000 after purchasing an additional 912 shares in the last quarter. 69.60% of the stock is currently owned by institutional investors and hedge funds.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).